Michael Mullin

Michael Mullin is an experienced molecular biologist and protein engineer with over 12 years of experience in the pharmaceutical industry.

Michael gained his Ph.D. at Queen’s University Belfast studying ligand-receptor interactions using phage display. He joined GSK in 2010 within the antibody engineering team and has experience of drug development with respect to challenging target classes, GPCRs and ion channels to support antibody discovery. He is currently leading the Protein Technologies group which focuses on developing novel high-throughput technologies for recombinant protein secretion/expression and purification.